histone deacetylase inhibitors (Genextra)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehistone deacetylase inhibitors (Genextra)
Drug Alias NameHDAC inhibitors (DAC/Genextra)HDAC inhibitors (DAC)histone deacetylase inhibitors (Genextra)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsNerve DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDAC Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDAC SrlGenextra
Active IndicationsN/A
Inactive IndicationsNerve DegenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A